Reusable Lancing Device Market Report 2026

Reusable Lancing Device Market Report 2026 Market Overview

• Reusable Lancing Device Market Report 2026 market size has reached to $14.43 billion in 2025 • Expected to grow to $23.25 billion in 2030 at a compound annual growth rate (CAGR) of 10.1% • Growth Driver: The Rising Global Prevalence Of Diabetes Fueling The Growth Of The Market Due To Increasing Sedentary Lifestyles And Obesity Rates • Market Trend: Hidden-Needle Technology Enhancing Reusable Lancing Device Convenience • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Reusable Lancing Device Market?

Reusable lancing devices are handheld medical devices used to obtain small capillary blood samples by pricking the skin, commonly for blood glucose monitoring in diabetic patients. These devices use replaceable sterile lancets and feature adjustable penetration depth settings to provide safer, more comfortable, and cost-effective blood sampling for repeated use. The main product types of reusable lancing device include automatic lancing devices and manual lancing devices. Automatic lancing devices refer to reusable medical devices designed to create controlled skin punctures for obtaining capillary blood samples with adjustable depth and improved patient comfort. The various applications involved are blood sample collection and blood glucose monitoring and they are utilized by end users including hospitals, clinics, and diagnostic centers.

What Is The Reusable Lancing Device Market Growth Forecast?

The reusable lancing device market size is expected to see rapid growth in the next few years. It will grow to $23.25 billion in 2030 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to growing adoption of home healthcare monitoring solutions, increasing demand for patient centric blood sampling devices, expansion of preventive healthcare screening programs, rising healthcare expenditure in emerging economies, development of more ergonomic and user friendly reusable lancing devices. Major trends in the forecast period include increasing adoption of safety engineered lancing devices for needlestick injury prevention, growing demand for adjustable depth lancing devices for personalized blood sampling, rising preference for reusable lancing devices to reduce long term monitoring costs, expansion of home based blood glucose monitoring practices, development of low pain blood sampling technologies for improved patient comfort.

What Is The Driver Of The Reusable Lancing Device Market?

The rising global prevalence of diabetes is expected to propel the growth of the reusable lancing device market going forward. Diabetes is a chronic metabolic disorder that occurs when the body cannot effectively regulate blood glucose levels due to insufficient insulin production or impaired insulin utilization. The rising global prevalence of diabetes is increasing due to growing obesity rates driven by sedentary lifestyles and unhealthy dietary habits. Reusable lancing devices support diabetes management by enabling convenient, accurate, and cost-effective blood glucose monitoring for patients requiring regular testing. For instance, in April 2024, according to the International Diabetes Federation, a Belgium-based non-profit diabetes organization, the number of adults living with diabetes reached 589 million in 2024 and is projected to increase to 853 million by 2050, representing a projected rise of nearly 44.8%. Therefore, the rising global prevalence of diabetes is driving the growth of the reusable lancing device industry

Key Players In The Global Reusable Lancing Device Market

Major companies operating in the reusable lancing device market report are F. Hoffmann-La Roche AG, Abbott Laboratories, Becton Dickinson and Company, B. Braun SE, Terumo Corporation, Nipro Corporation, Ascensia Diabetes Care Holdings AG, ARKRAY Inc., MED TRUST Handelsges.m.b.H., TaiDoc Technology Corporation, Bionime Corporation, Visiomed Group SA, Norditalia Elettromedicali S.r.l., Pharma Supply Inc., KETO-MOJO, LaMeditech Co. Ltd., Nova Diabetes Care, MHC Medical Products LLC, Owen Mumford Ltd., Boen Healthcare Co. Ltd., LifeScan Inc., AgaMatrix Inc., GlucoRx Ltd., Osang Healthcare Co. Ltd., Major Bioscience Co. Ltd.

Global Reusable Lancing Device Market Trends and Insights

Major companies operating in the reusable lancing device market are focusing on developing advanced user-friendly blood sampling technologies, such as cap-free reusable lancing systems with hidden-needle mechanisms, to improve patient comfort, simplify blood collection procedures, and enhance diabetes self-monitoring convenience. Cap-free reusable lancing systems are blood sampling devices designed for repeated use that eliminate the need for a protective cap, allowing the lancing mechanism to be cocked and activated directly for quicker and more convenient operation. For instance, in June 2025, SteriLance Medical, a China-based medical device manufacturer, launched the Onestep Lancing Device in Europe. The reusable lancing device features a cap-free design and hidden-needle technology that reduces preparation steps during blood sampling procedures. The system is designed to support safer and more convenient capillary blood collection while improving ease of use for diabetes patients conducting routine self-monitoring of blood glucose (SMBG). The launch strengthens the company’s diabetes care portfolio by addressing increasing demand for simplified and patient-centric reusable lancing solutions in home healthcare settings.

What Are Latest Mergers And Acquisitions In The Reusable Lancing Device Market?

In March 2024, Medical Technology and Devices (MTD), an Italy-based manufacturer of medical devices and diabetes care solutions, acquired the pen needle and blood glucose monitoring (BGM) businesses of Ypsomed Holding AG for an undisclosed amount. Through this acquisition, Medical Technology and Devices (MTD) aims to strengthen its global diabetes care portfolio by expanding its blood glucose monitoring capabilities, increasing pen needle production capacity, and enhancing its position in the diabetes self-care market. Ypsomed Holding AG is a Switzerland-based developer of diabetes care solutions, including blood glucose monitoring systems, pen needles, insulin delivery devices, and self-management technologies for diabetes patients.

What Defines the Reusable Lancing Device Market?

The reusable lancing device market consists of sales of reusable blood sampling devices, lancets, adjustable lancing pens, and related accessories. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Reusable Lancing Device Market Report 2026?

The reusable lancing device market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the reusable lancing device industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.